Remdesivir Improves Time to COVID-19 Recovery; Malaria Treatment Approved

Inbox

x

MPR Daily Dose <editor@email.empr.com> Unsubscribe

3:02 AM (18 hours ago)

to me

If you are having trouble viewing this email, click here.

MUST READS Remdesivir Improves Time To Recovery for Patients Hospitalized With COVID-19 Vesicare LS Approved for Neurogenic Detrusor Overactivity FDA Approval Expands Access of Artesunate for Malaria Treatment Clinical, Anatomic Improvements With Dupilumab in Eosinophilic Esophagitis Study Lumasiran Granted Priority Review for Primary Hyperoxaluria Type 1 FEATURE Pharmacogenetics in Antidepressant Selection for Major Depressive Disorder CME/CE Spotlight Dispelling the Myths of Influenza Management AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME